Hostname: page-component-8448b6f56d-mp689 Total loading time: 0 Render date: 2024-04-23T19:31:27.281Z Has data issue: false hasContentIssue false
  • English
  • Français

Hospital outbreak of the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) delta variant in partially and fully vaccinated patients and healthcare workers in Toronto, Canada

Part of: SARS-CoV-2/COVID-19

Published online by Cambridge University Press:  28 October 2021

Erica K. Susky Open the ORCID record for Erica K. Susky [Opens in a new window] ,
Susy Hota Open the ORCID record for Susy Hota [Opens in a new window] ,
Irene E. Armstrong ,
Tony Mazzulli ,
Shaindel Kestenberg ,
Leanne K. Casaubon ,
John Granton ,
Carly Rebelo ,
Erika Bartels  and
Jeff Wrana
...Show all authors
Erica K. Susky
Affiliation:
Infection Prevention and Control Department, University Health Network, Toronto, Ontario, Canada
Susy Hota
Affiliation:
Infection Prevention and Control Department, University Health Network, Toronto, Ontario, Canada Division of Infectious Diseases, University Health Network, Toronto, Ontario, Canada Department of Medicine, University of Toronto, Toronto, Ontario, Canada
Irene E. Armstrong
Affiliation:
Toronto Public Heath, Toronto, Ontario, Canada
Tony Mazzulli
Affiliation:
Department of Microbiology, Mount Sinai Health System and University Health Network, Toronto, Ontario, Canada
Shaindel Kestenberg
Affiliation:
Department of Health Services, University Health Network, Toronto, Ontario, Canada
Leanne K. Casaubon
Affiliation:
Department of Medicine, University of Toronto, Toronto, Ontario, Canada Division of Neurology, University Health Network, Toronto, Ontario, Canada
John Granton
Affiliation:
Department of Medicine, University of Toronto, Toronto, Ontario, Canada Department of Health Services, University Health Network, Toronto, Ontario, Canada Division of Pulmonary and Critical Care, University Health Network, Toronto, Ontario, Canada
Carly Rebelo
Affiliation:
Infection Prevention and Control Department, University Health Network, Toronto, Ontario, Canada Division of Infectious Diseases, University Health Network, Toronto, Ontario, Canada
Erika Bartels
Affiliation:
Toronto Public Heath, Toronto, Ontario, Canada
Jeff Wrana
Affiliation:
Lunenfeld-Tanenbaum Research Institute Mount Sinai Hospital, Toronto, Ontario, Canada
Alon Vaisman*
Affiliation:
Infection Prevention and Control Department, University Health Network, Toronto, Ontario, Canada Division of Infectious Diseases, University Health Network, Toronto, Ontario, Canada Department of Medicine, University of Toronto, Toronto, Ontario, Canada
*
Author for correspondence: Dr Alon Vaisman, E-mail: alon.vaisman@uhn.ca
Get access Rights & Permissions [Opens in a new window]

Abstract

The severe acute respiratory coronavirus virus 2 (SARS-CoV-2) delta variant is highly transmissible, and current vaccines may have reduced effectiveness in preventing symptomatic infection. Using epidemiological and genomic analyses, we investigated an outbreak of the variant in an acute-care setting among partially and fully vaccinated individuals. Effective outbreak control was achieved using standard measures.

Keywords

COVID-19outbreaknosocomial transmission
Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 44 , Issue 2 , February 2023 , pp. 328 - 331
Check for updates
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

SARS-CoV-2 variant classifications and definitions. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/science/about-epidemiology/studying-the-disease.html. Published 2020. Accessed July 11, 2021.Google Scholar
Sheikh, A, McMenamin, J, Taylor, B, Robertson, C. SARS-CoV-2 delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness. Lancet 2021;397:2461–2462.CrossRefGoogle ScholarPubMed
Lopez Bernal, J, Andrews, N, Gower, C, et al. Effectiveness of COVID-19 vaccines against the B.1.617.2 (delta) variant. N Engl J Med 2021;385:585–594.CrossRefGoogle ScholarPubMed
Aynaud, M-M, Hernandez, JJ, Barutcu, S, et al. A multiplexed, next-generation sequencing platform for high-throughput detection of SARS-CoV-2. Nat Commun 2021;12:1405.CrossRefGoogle ScholarPubMed
Qin, J, You, C, Lin, Q, Hu, T, Yu, S, Zhou, X-H. Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study. Sci Adv 2020;6(33):eabc1202.CrossRefGoogle Scholar
Keehner, J, Horton, LE, Binkin, NJ, et al. Resurgence of SARS-CoV-2 infection in a highly vaccinated health system workforce. N Engl J Med 2021;385:1330–1332.CrossRefGoogle Scholar
Fowlkes, A. Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection among frontline workers before and during B.1.617.2 (delta) variant predominance—eight US locations, December 2020–August 2021. Morb Mortal Wkly Rep 2021;70:1167–1169.CrossRefGoogle ScholarPubMed
Teran, RA, Walblay, KA, Shane, EL, et al. Postvaccination SARS-CoV-2 infections among skilled nursing facility residents and staff members—Chicago, Illinois, December 2020–March 2021. Am J Transplant 2021;21:2290–2297.CrossRefGoogle Scholar
Cavanaugh, AM, Fortier, S, Lewis, P, et al. COVID-19 outbreak associated with a SARS-CoV-2 R.1 lineage variant in a skilled nursing facility after vaccination program—Kentucky, March 2021. Morb Mortal Wkly Rep 2021;70:639–643.CrossRefGoogle Scholar
COVID Data Tracker. Centers for Disease Control and Prevention website. https://covid.cdc.gov/covid-data-tracker. Published 2020. Accessed September 29, 2021.Google Scholar